Export

Pretomanid
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04AK08
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Pretomanid
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid > tablet: 200 mg
EML status history
First added in 2023 (TRS 1049)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Main patents have expired but secondary patents might remain active in some jurisdictions. For more information on specific patents and license status for developing countries visit www.MedsPal.org
Wikipedia
Pretomanid
DrugBank
Pretomanid
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the inclusion of pretomanid on the complementary list of the EML for treatment of multidrug-resistant or rifampicin-resistant tuberculosis, in a combination regimen with bedaquiline, linezolid with or without moxifloxacin.